目前和新兴的血友病A和B的基因疗法
Radoslaw Kaczmarek1, Wolfgang Miesbach2, Margareth C Ozelo3
1Wells Centre for Paediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.
概括
血友病的基因疗法提供了长期的因子正常化,但面临着难以预测的有效性和潜在毒性的挑战. 需要进一步的创新来克服局限性并实现广泛的治疗.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 生物技术是生物技术.
背景情况:
- 血友病A和B的第一个基因疗法现在已经商业化,在一些患者中显示出因子水平的长期正常化.
- 使用腺相关病毒 (AAV) 载体基因治疗的众多临床项目正处于发展的各个阶段.
研究的目的:
- 评估目前用于治疗血友病的腺相关病毒 (AAV) 载体基因疗法的长期疗效和安全性.
- 为了确定与血友病治疗中AAV基因疗法相关的局限性和挑战.
- 探索潜在的未来方向和血友病的替代基因转移系统.
主要方法:
- 1/2期和3期临床研究的多年随访.
- 对疗效数据的分析,包括因子 (F) VIII和因子 (F) IX的水平.
- 评估安全结果,包括肝脏毒性和潜在的长期风险,如致癌性.
主要成果:
- 基因疗法证明了长期的,有时是治愈性的疗效,但具有显著的可变性和不可预测性.
- 在血友病A和B试验的第一年观察到低度肝毒性.
- 对AAV载体的免疫反应阻止了重复剂量,高剂量整合引发了致性问题.
结论:
- AAV基因疗法是有价值的新选择,但不是对血友病的普遍治疗方法.
- 目前的AAV平台功能强大但不完美,有效性变化和安全性问题需要终身监测.
- 替代基因编辑和非病毒载体系统正在开发中,以解决当前的局限性并改善患者的治疗结果.
相关概念视频
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
01:59CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
00:49What is Genetic Engineering?
74.1K
Overview
74.1K
01:09Recombinant DNA
94.4K
Overview
94.4K
01:22Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328